Current Drug Targets


Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556


Become EABM
Become Reviewer

Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges free to download

Volume:18   Issue: 15
Pp: 1687-1688
Jun Ren and Yingmei Zhang
DOI: 10.2174/138945011815171019092703

New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury

Volume:18   Issue: 15
Pp: 1689-1711
Kai Yee Chin, Chengxue Qin, Lauren May, Rebecca H. Ritchie and Owen L. Woodman*
DOI: 10.2174/1389450116666151001112020

Progress in Therapies for Myocardial Ischemia Reperfusion Injury

Volume:18   Issue: 15
Pp: 1712-1721
Hong-jie Chi, Mu-lei Chen, Xin-chun Yang, Xiang-min Lin, Hao Sun, Wen-shu Zhao, Dan Qi, Jia-lu Dong and Jun Cai*
DOI: 10.2174/1389450117666160401120308

Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases

Volume:18   Issue: 15
Pp: 1779-1784
Hui Fu, Min Ni, Ji-Kuai Chen, Ting Zhao, Ya-Ping Deng, Dong-Jie Li, Guo-Jun Jiang* and Fu-Ming Shen*
DOI: 10.2174/1389450116666150825123247

Targeting Apelinergic System in Cardiometabolic Disease

Volume:18   Issue: 15
Pp: 1785-1791
Rui Guo, Olivia Rogers and Sreejayan Nair*
DOI: 10.2174/1389450117666160613105152

Cardiac Tumors: Clinical Perspective and Therapeutic Considerations

Volume:18   Issue: 15
Pp: 1805-1809
Dylan Y. Ren, Nathan D. Fuller, Sara A.B. Gilbert and Yingmei Zhang*
DOI: 10.2174/1389450117666160703162111